Product Theater – Amgen: Managing Continued Treatment for Chronic Moderate to Severe Plaque Psoriasis

Faculty: Paul Yamauchi, MD, PhD Dr. Yamauchi reviewed the long term use of Enbrel (etanercept) for the treatment of moderate to severe plaque psoriasis. Psoriasis is an immune mediated disease characterized by erythematous scaling plaques and patches. Enbrel is a treatment for patients ages 4 and older who are candidates for systemic therapy or phototherapy …